The effect of quetiapine on psychotic-like symptoms in borderline personality disordered patients: A randomised placebo-controlled trial
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2009
At a glance
- Drugs Quetiapine (Primary)
- Indications Borderline personality disorders
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 16 Jun 2009 Trial phase changed from III to II as reported by ClinicalTrials.gov.
- 03 Sep 2008 Results presented at ECNP 2008.
- 17 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.